Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Cash from Operations (2016 - 2025)

Fennec Pharmaceuticals filings provide 15 years of Cash from Operations readings, the most recent being 5962000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 304.48% to 5962000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 12473000.0, a 146.23% decrease, with the full-year FY2025 number at 12473000.0, down 146.23% from a year prior.
  • Cash from Operations hit 5962000.0 in Q4 2025 for Fennec Pharmaceuticals, down from 1493000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 39047000.0 in Q1 2024 to a low of 8387000.0 in Q2 2024.
  • Median Cash from Operations over the past 5 years was 3639500.0 (2021), compared with a mean of 1481166.67.
  • Biggest five-year swings in Cash from Operations: skyrocketed 800.14% in 2024 and later tumbled 304.48% in 2025.
  • Fennec Pharmaceuticals' Cash from Operations stood at 2958000.0 in 2021, then tumbled by 129.95% to 6802000.0 in 2022, then increased by 28.55% to 4860000.0 in 2023, then skyrocketed by 69.67% to 1474000.0 in 2024, then tumbled by 304.48% to 5962000.0 in 2025.
  • The last three reported values for Cash from Operations were 5962000.0 (Q4 2025), 1493000.0 (Q3 2025), and 3686000.0 (Q2 2025) per Business Quant data.